Variant report
Variant | esv2479479 |
---|---|
Chromosome Location | chr2:183315368-183316896 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140012638 | chr2:183315368-183315369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556400126 | chr2:183315370-183315371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371417833 | chr2:183315448-183315449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376832541 | chr2:183315454-183315455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs193186613 | chr2:183315493-183315494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542024055 | chr2:183315511-183315512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561853848 | chr2:183315518-183315519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75832645 | chr2:183315521-183315522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs80190285 | chr2:183315522-183315523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572023950 | chr2:183315530-183315531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185511430 | chr2:183315585-183315586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190829953 | chr2:183315586-183315587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149503820 | chr2:183315595-183315596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374287211 | chr2:183315597-183315598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555139005 | chr2:183315615-183315616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149999800 | chr2:183315639-183315640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550099732 | chr2:183315640-183315641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115148011 | chr2:183315653-183315654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537666292 | chr2:183315666-183315667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114856029 | chr2:183315709-183315710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180692546 | chr2:183315719-183315720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2368252 | chr2:183315726-183315727 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs374914950 | chr2:183315734-183315735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570522514 | chr2:183315735-183315736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75436263 | chr2:183315783-183315784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183838790 | chr2:183315791-183315792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79854433 | chr2:183315807-183315808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539401977 | chr2:183315823-183315824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556454390 | chr2:183315824-183315825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111782621 | chr2:183315831-183315832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577693685 | chr2:183315919-183315920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200481194 | chr2:183316121-183316122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112771184 | chr2:183316148-183316149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7601239 | chr2:183316163-183316164 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs34103461 | chr2:183316191-183316192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs553529109 | chr2:183316192-183316193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13387691 | chr2:183316204-183316205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13387701 | chr2:183316235-183316236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573577228 | chr2:183316262-183316263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62188289 | chr2:183316268-183316269 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs562375681 | chr2:183316395-183316396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142463709 | chr2:183316397-183316398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs151337022 | chr2:183316447-183316448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114206921 | chr2:183316489-183316490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369081965 | chr2:183316497-183316498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542854741 | chr2:183316575-183316576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559275078 | chr2:183316591-183316592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528248846 | chr2:183316604-183316605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116330234 | chr2:183316610-183316611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188553908 | chr2:183316640-183316641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:183298800-183320800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:183313000-183321400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr2:183313000-183342600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr2:183313800-183315800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr2:183313800-183320800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr2:183314800-183315400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |